Article -> Article Details
| Title | Global Lithotripters Market Evaluation Covering Medical Tech Progress and Growth Projections |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Lithotripters Market |
| Owner | Imarc |
| Description | |
| Market Overview The global Lithotripters Market was valued at USD 1.79 Billion in 2024 and is expected to grow to USD 2.53 Billion by 2033. The market is projected to expand at a CAGR of 3.73% from 2025 to 2033. Growth drivers include increasing prevalence of kidney stones, particularly in North America, advancements in lithotripsy technology, and an aging population favoring minimally invasive treatments. Study Assumption Years
Lithotripters Market Key Takeaways
Sample Request Link: https://www.imarcgroup.com/lithotripters-market/requestsample Market Growth Factors The lithotripters market growth is primarily driven by the rising global incidence of kidney stones, known as urolithiasis. Factors such as lethargic lifestyle, inappropriate dietary practices, and increasing obesity rates contribute significantly to this rise. For instance, the prevalence of kidney stones in the United States increased from 3.8% in the late 1970s to 8.8% in the late 2000s, with men facing an 11% risk and women a 9% risk. This growing patient pool escalates demand for lithotripsy, an effective and non-invasive stone disintegration procedure using high-intensity shock waves. Technological advancements have propelled the lithotripters market as devices have become portable and compact, enhancing accuracy and patient acceptance. Innovations such as extracorporeal shock wave lithotripsy offer non-invasive and efficient stone disintegration. For example, improved imaging techniques enable better stone targeting, and devices have become smaller and safer, improving patient convenience during hospital treatments. The FDA granted Breakthrough Device Designation in January 2022 to Applaud Medical's Acoustic Enhancer, which complements laser lithotripsy for breaking calcium-based kidney stones, exemplifying the sector's innovation. Demographic shifts further stimulate market growth, particularly the expanding geriatric population more prone to kidney stones. The population above 65 years nearly doubled from 5.5% in 1974 to 10.3% in 2024, increasing demand for minimally invasive kidney stone treatments like lithotripsy. Awareness campaigns and advanced technologies have boosted adoption rates, especially in emerging economies, positioning the aging population and enhanced treatment awareness as principal market drivers. Market Segmentation Analysis by Device:
Description: These devices vary by energy source and mechanism, enabling targeted treatment of stones within the urinary tract. Analysis by Application:
Description: Applications cover various stone locations in the urinary and biliary systems, driven by lifestyle and metabolic disease factors. Analysis by End User:
Description: End users reflect healthcare delivery settings, with hospitals dominating due to comprehensive capabilities and patient volume. Regional Insights North America holds the largest market share in 2024, driven by a high prevalence of kidney stones linked to sedentary lifestyles and dietary habits. The region benefits from developed healthcare infrastructure, effective reimbursement policies, a broad health facility network, dominant manufacturing bases, and strong R&D fostering innovation in lithotripsy systems. Awareness campaigns and increased outpatient surgical centers further drive demand, consolidating North America's leading position in the global lithotripters market. Recent Developments & News In May 2024, Dornier Medtech launched Urogpt, an AI tool providing instant advice to kidney stone patients, reflecting a commitment to digital patient solutions. In February 2024, INHS Asvini inaugurated a new Urology Department equipped with an advanced ESWL machine for non-invasive kidney stone fragmentation. January 2024 saw Siemens Healthineers introduce the Artis Q.GO X-Ray System, a compact and mobile solution for urology clinics and small hospitals, enhancing lithotripsy accessibility in underserved areas. Key Players
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization. Request for customization: https://www.imarcgroup.com/request?type=report&id=6698&flag=E About Us IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. Contact Us IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No: (D) +91 120 433 0800 United States: +1-201971-6302 | |